lndomethacin and Aspirin Do Not Inhibit the Antiviral or Anti-proliferative
Actions of Interferon (Accepted 13 July 1982) SUMMARY Neither indomethacin nor aspirin, at concentrations which inhibited the formation of prostaglandins and prevented the interferon-induced increase in the intracellular concentration of cyclic GMP, had any significant effect on the development of the interferon-induced antiviral state either in mouse L 1210 cells challenged with vesicular stomatitis virus or in mice infected with encephalomyocarditis virus. Furthermore, neither drug had any significant effect on the interferon-induced inhibition of cell multiplication in cultures of mouse leukaemia L1210 cells. The differences in the effects of these cyclo-oxygenase inhibitors on different interferon effects may provide some insight into the different pathways of interferon action.
Administration of purified human leukocyte interferon-~ to patients or healthy volunteers induces influenza-like symptoms together with leucopenia and thrombocytopenia (Scott et al., 1981) . Some of the undesirable symptoms such as increases in pulse rate and body temperature are abrogated when indomethacin is administered with interferon (Scott et al., 1981) . Cyclooxygenase inhibitors, including indomethacin and aspirin have recently been reported to inhibit both the antiviral (Pottathil et al., 1980) and the anti-proliferative (R. J. Brideau & D. A. Stringfellow, personal communication) actions of interferon, which might preclude their use in conjugation with interferon therapy for virus and neoplastic diseases.
We have previously shown that indomethacin or aspirin can inhibit one action of interferon, the induction of cyclic GMP (Tovey et al., 1979; Tovey & Rochette-Egly, 1981) , without affecting in the same cell population a second action of interferon, enhancement of natural killer cell cytotoxicity (Tovey et al., 1982) . In the present study we report, in contrast to a previous report (Pottathil et al., 1980) , that neither indomethacin nor aspirin, at concentrations which inhibited the formation of both prostaglandins and cyclic GMP, had any significant effect on the development of the interferon-induced antiviral state either in mouse L1210 cells challenged with vesicular stomatitis virus (VSV), or in mice infected with encephalomyocarditis virus (EMC). Furthermore, neither drug had any significant effect on the interferon-induced inhibition of cell multiplication in cultures of mouse leukaemia L1210 cells.
Mouse leukaemia L1210 cells were cultivated in static suspension culture in RPMI 1640 medium (Flow Laboratories) supplemented with 109/oo heat-inactivated foetal calf serum. Cell number was determined by counting cells in a haemocytometer in the presence of trypan blue. Mouse C243 cell interferon was prepared, purified and assayed as previously described (Tovey et al., 1974) . VSV (Indiana strain) was propagated in L929 cells. Inhibition of virus yield was determined 18 h after the addition of VSV at the m.o.i, indicated. Cultures of L1210 cells were then frozen and thawed three times, centrifuged (2000 rev/min for 10 min) and the supernatant titrated on L929 cells. VSV titres are expressed as TCID50/200 ~tl. Cyclic GMP content was determined after ether extraction and purification of samples on Dowex AGI x 8 using a radioimmune assay (Amersham International) as previously described by Rochette & Castagna (1977) . Recovery (70 to 80~) was monitored with 1 nCi 3H-labelled GMP, and the specificity of the assay was checked with 3' : Y-cyclic nucleotide phosphodiesterase as previously described by Rochette & Castagna (1977) . Results are expressed as the mean of four replicates in pmol/106 cells.
To determine whether an active cyclo-oxygenase system was necessary for the development of the antiviral state in interferon-treated cells, mouse L1210 cells were pretreated for 30 rain with either indomethacin or aspirin at concentrations of 10-7 to 10 -4 M prior to interferon treatment, 0022-1317/82/0000-5282 $02.00 © 1982 SGM Virus yield reduction (log lo) 2'9 2'3 2"9 2"5 2-5 2.1 2.1 2.0 1.9 1.3 1.2 0-9 1-9 2.1 1.9 1.3 2.5 t-7 1.5 1.4 1.6 * Mouse L1210 cells were pretreated for 30 min with either indomethacin or aspirin at the concentrations indicated prior to treatment with interferon (2000 IU/ml) for 24 h. The cells were then centrifuged (2000 rev/min for 10 rain) and resuspended in medium without interferon but containing VSV at an m.o.i, of 0-1 for a 1 h adsorption period at 37 °C. The ceils were then centrifuged (2000 rev/min for 10 min) washed twice and resuspended in nutrient medium, and the replication of VSV was determined after 18 h incubation at 37 °C.
t Infected with VSV at an m.o.i, of 0-0l. :~ Treated with 400 IU/ml interferon.
which was then carried out in the continued presence of the inhibitors for 24 h. The effect of this treatment on the replication of VSV in interferon-treated L1210 cells was then determined 18 h after removal of interferon. In a total of seven experiments, inhibition of VSV replication was found to be as marked in cultures of L1210 cells treated with interferon in the presence of either indomethacin or aspirin as in cultures of L1210 cells treated with interferon in the absence of inhibitors (Table 1) . Similar results were obtained at interferon concentrations of 400 to 2000 international units (IU)/ml and at m.o.i.'s of VSV of either 0-01 or 0.1. Neither inhibitor alone had any significant effect on VSV replication at the concentrations employed (Table 1) .
It is important to emphasize that in these experiments indomethacin or aspirin suppressed the interferon-induced increase in cyclic GMP (data not shown). Likewise, it has been reported that these inhibitors, at the concentrations used in this study, also suppress the synthesis of prostaglandins (Glass et al., 1977; Chandrabose et al., 1981) .
Treatment of Swiss mice with 1.2 × 106 IU of mouse interferon 4 h before infection with 100 LDs0 of EMC virus reduced the incidence of mortality from 100% in control virus-infected animals to approx. 50% in the interferon-treated group (Fig. la) . Administration of indomethacin (8 ~tg/animal) or aspirin (500 vtg/animal) 1 h before treatment with the interferon did not diminish (or enhance) the protective effect of interferon (Fig. 1) . Neither indomethacin (Fig. 1 b) nor aspirin ( Fig. 1 c) had any significant effect on the survival of control virus-infected mice.
Culture of mouse leukaemia LI210 cells with mouse interferon (10, 100 or 1000 IU/ml) resulted in a dose-dependent inhibition of cell multiplication (data not shown). The inhibition of cell multiplication was as marked in cultures of L1210 cells treated with interferon in the presence of indomethacin (2.5 or 5 pg/ml) or aspirin (18 or 100 ~g/ml) as in cultures treated with interferon alone. the earlier studies the differences obtained were not large and may have been peculiar to the particular experimental conditions used. Thus, some of the effects of interferon, such as fever (Scott et al., 1981) or the induction of cyclic nucleotides (Tovey et al., 1979) which may be related to the synthesis of prostaglandins, can be prevented by cyclo-oxygenase inhibitors such as indomethacin. Other effects (i.e. antiviral and anti-proliferative) appear from our results not to be affected by these drugs, at least in the systems which we have studied. These differences in the effects of some cyclo-oxygenase inhibitors on different interferon effects may provide some insight into the different pathways of interferon action. Furthermore, our in vivo results suggest that aspirin and indomethacin can be administered to patients receiving interferon therapy.
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